243 related articles for article (PubMed ID: 8788444)
1. Co-treatment with MK-801 potentiates naloxone-precipitated morphine withdrawal in the isolated spinal cord of the neonatal rat.
Bell JA; Beglan CL
Eur J Pharmacol; 1995 Dec; 294(1):297-301. PubMed ID: 8788444
[TBL] [Abstract][Full Text] [Related]
2. MK-801 blocks the expression but not the development of tolerance to morphine in the isolated spinal cord of the neonatal rat.
Bell JA; Beglan CL
Eur J Pharmacol; 1995 Dec; 294(1):289-96. PubMed ID: 8788443
[TBL] [Abstract][Full Text] [Related]
3. Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance.
Manning BH; Mao J; Frenk H; Price DD; Mayer DJ
Pain; 1996 Sep; 67(1):79-88. PubMed ID: 8895234
[TBL] [Abstract][Full Text] [Related]
4. The NMDA receptor antagonist MK-801 differentially modulates mu and kappa opioid actions in spinal cord in vitro.
Feng J; Kendig JJ
Pain; 1996 Aug; 66(2-3):343-9. PubMed ID: 8880858
[TBL] [Abstract][Full Text] [Related]
5. Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats.
Watanabe T; Nakagawa T; Yamamoto R; Maeda A; Minami M; Satoh M
Jpn J Pharmacol; 2002 Apr; 88(4):399-406. PubMed ID: 12046982
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of the NMDA receptor antagonist, dizocilpine (MK-801), on the development of morphine dependence.
Makimura M; Sugimoto H; Shinomiya K; Kabasawa Y; Fukuda H
J Toxicol Sci; 1996 May; 21(2):135-41. PubMed ID: 8780997
[TBL] [Abstract][Full Text] [Related]
7. Blockade of ionotropic glutamatergic transmission in the ventral tegmental area attenuates the physical signs of morphine withdrawal in rats.
Wang HL; Zhao Y; Xiang XH; Wang HS; Wu WR
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1079-87. PubMed ID: 15610920
[TBL] [Abstract][Full Text] [Related]
8. Memantine presents different effects from MK-801 in motivational and physical signs of morphine withdrawal.
Maldonado C; Cauli O; Rodríguez-Arias M; Aguilar MA; Miñarro J
Behav Brain Res; 2003 Sep; 144(1-2):25-35. PubMed ID: 12946592
[TBL] [Abstract][Full Text] [Related]
9. Effect of glutamate receptor antagonists on place aversion induced by naloxone in single-dose morphine-treated rats.
Kawasaki Y; Jin C; Suemaru K; Kawasaki H; Shibata K; Choshi T; Hibino S; Gomita Y; Araki H
Br J Pharmacol; 2005 Jul; 145(6):751-7. PubMed ID: 15880144
[TBL] [Abstract][Full Text] [Related]
10. Ethanol attenuation of morphine dependence: comparison to dizocilpine.
Shoemaker WJ; Kosten TA; Muly SM
Psychopharmacology (Berl); 1997 Nov; 134(1):83-7. PubMed ID: 9399370
[TBL] [Abstract][Full Text] [Related]
11. Behavioral effects of MK-801 in morphine-dependent and non-dependent mice.
Belozertseva I; Zvartau E; Bespalov A
Life Sci; 1996; 58(4):PL55-61. PubMed ID: 8538362
[TBL] [Abstract][Full Text] [Related]
12. Interactive effects of MK-801 and morphine on EEG, EEG power spectra and behavior in rats: II. Morphine dependence.
Haberny KA; Young GA
Eur J Pharmacol; 1994 Aug; 261(1-2):11-6. PubMed ID: 8001632
[TBL] [Abstract][Full Text] [Related]
13. The contribution of supraspinal, peripheral and intrinsic spinal circuits to the pattern and magnitude of Fos-like immunoreactivity in the lumbar spinal cord of the rat withdrawing from morphine.
Rohde DS; McKay WR; Chang DS; Abbadie C; Basbaum AI
Neuroscience; 1997 Sep; 80(2):599-612. PubMed ID: 9284361
[TBL] [Abstract][Full Text] [Related]
14. Contribution of sacral spinal cord neurons to the autonomic and somatic consequences of withdrawal from morphine in the rat.
Rohde DS; McKay WR; Abbadie C; Basbaum AI
Brain Res; 1997 Jan; 745(1-2):83-95. PubMed ID: 9037396
[TBL] [Abstract][Full Text] [Related]
15. Spinal NMDA receptor--nitric oxide mediation of the expression of morphine withdrawal symptoms in the rat.
Buccafusco JJ; Terry AV; Shuster L
Brain Res; 1995 May; 679(2):189-99. PubMed ID: 7633880
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of morphine dependence and withdrawal by glycine B site antagonists in rats.
Kotlińska J
Pharmacol Biochem Behav; 2001 Jan; 68(1):157-61. PubMed ID: 11274720
[TBL] [Abstract][Full Text] [Related]
17. Naltrexone-precipitated morphine withdrawal in infant rat is attenuated by acute administration of NOS inhibitors but not NMDA receptor antagonists.
Zhu H; Barr GA
Psychopharmacology (Berl); 2000 Jun; 150(3):325-36. PubMed ID: 10923761
[TBL] [Abstract][Full Text] [Related]
18. Further evidence for a role of NMDA receptors in the locus coeruleus in the expression of withdrawal syndrome from opioids.
Tokuyama S; Zhu H; Oh S; Ho IK; Yamamoto T
Neurochem Int; 2001 Aug; 39(2):103-9. PubMed ID: 11408088
[TBL] [Abstract][Full Text] [Related]
19. The effect of the glycine/NMDA receptor antagonist, (+)-HA966, on morphine dependence in neuropathic rats.
Christensen D; Guilbaud G; Kayser V
Neuropharmacology; 2000 Jul; 39(9):1589-95. PubMed ID: 10854903
[TBL] [Abstract][Full Text] [Related]
20. Dextromethorphan attenuates morphine withdrawal syndrome in neonatal rats passively exposed to morphine.
Yeh GC; Tao PL; Chen JY; Lai MC; Gao FS; Hu CL
Eur J Pharmacol; 2002 Oct; 453(2-3):197-202. PubMed ID: 12398904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
